GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (MIL:1ZTS) » Definitions » Ending Cash Position

Zoetis (MIL:1ZTS) Ending Cash Position : €1,898 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Zoetis Ending Cash Position?

Zoetis's Ending Cash Position for the quarter that ended in Dec. 2024 was €1,898 Mil.

Zoetis's quarterly Ending Cash Position increased from Jun. 2024 (€1,462 Mil) to Sep. 2024 (€1,544 Mil) and increased from Sep. 2024 (€1,544 Mil) to Dec. 2024 (€1,898 Mil).

Zoetis's annual Ending Cash Position declined from Dec. 2022 (€3,380 Mil) to Dec. 2023 (€1,872 Mil) but then increased from Dec. 2023 (€1,872 Mil) to Dec. 2024 (€1,898 Mil).


Zoetis Ending Cash Position Historical Data

The historical data trend for Zoetis's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Ending Cash Position Chart

Zoetis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,962.49 3,084.23 3,380.46 1,871.60 1,897.59

Zoetis Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,871.60 1,817.00 1,462.25 1,544.31 1,897.59

Zoetis Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Zoetis's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1949.155+-51.57
=1,898

Zoetis's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1636.87+260.715
=1,898


Zoetis Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Zoetis's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Zoetis Business Description

Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis Headlines

No Headlines